Guru Ownership Trend
Guru Analysis for UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $174.8 M.
Top institutional holders include Jefferies Group and Steven Cohen.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $58.4 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Catherine Wood reduced exposure by 12.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for UroGen Pharma Ltd. (URGN)
Major holders include Jefferies Group ($80.95 M), Steven Cohen ($56.14 M), Cliff Asness ($5.49 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.05 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $58.4 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited URGN. The total reported sell value was $516,561.54.
Yes, 2 managers opened new positions in URGN, and 1 increased their existing holdings. The total reported buy value was $58.92 M.